BioMed Research International

BioMed Research International / 2013 / Article
Special Issue

Novel Drugs Development for Cardio-/ Cerebrovascular Diseases

View this Special Issue

Research Article | Open Access

Volume 2013 |Article ID 201614 |

Yi-Li Wang, Kwok-Keung Lam, Pao-Yun Cheng, Ching-Wen Kung, Shu-Ying Chen, Chun-Chih Chao, Hwong-Ru Hwang, Ming-Ting Chung, Yen-Mei Lee, "The Cardioprotective Effect of Hypertonic Saline Is Associated with Inhibitory Effect on Macrophage Migration Inhibitory Factor in Sepsis", BioMed Research International, vol. 2013, Article ID 201614, 10 pages, 2013.

The Cardioprotective Effect of Hypertonic Saline Is Associated with Inhibitory Effect on Macrophage Migration Inhibitory Factor in Sepsis

Academic Editor: Joen-Rong Sheu
Received02 Oct 2013
Accepted08 Nov 2013
Published26 Nov 2013


Sepsis can cause myocardial dysfunction, which contributes to the high mortality of sepsis. Hypertonic saline (HS) has been reported to increase myocardial contractility in sepsis. In the present study, mechanisms of action of HS resuscitation (4 mL of 7.5% NaCl per kilogram) on cardiac function have been evaluated in septic rats. HS was administered 1 h after LPS (10 mg/kg, i.v.) challenge. The mean arterial blood pressure significantly decreased 4 h after LPS challenge, and septic shock was observed at the end of experiment (6 h). Posttreatment with HS prevented hypotension caused by LPS and significantly improved cardiac function, evidenced by increases in left ventricular developed pressure, mean and . The amplitude of electrical-stimulated intracellular Ca2+ transient in isolated single cardiomyocytes was significantly reduced after 6 h LPS insult, which was recovered by HS. In addition, LPS resulted in significant increases in neutrophil myeloperoxidase activity, macrophage migration inhibitory factor (MIF), and NF- B phospho-p65 protein levels in myocardium at 6 h, which were significantly attenuated by HS. In conclusion, HS improved myocardial contractility and prevented circulatory failure induced by endotoxemia, which may attribute to improvement of intracellular calcium handling process and inhibitory effects on neutrophil infiltration and MIF production in hearts.

1. Introduction

Multiple organ failure is a leading cause of mortality in sepsis, and myocardial depression is the most common organ dysfunction. Sepsis-induced cardiac dysfunction is characterized by decreased myocardial contractility, impaired ventricular response to fluid therapy, and ventricular dilatation [1]. Fluid resuscitation is one of the first-line cornerstone therapies and to support the cardiac function in severe sepsis [2]. Isotonic fluid (Ringer’s lactate or normal saline [0.9% NaCl]) administration can restore the body fluid and microvascular perfusion. In clinical therapy, small volume of hypertonic saline (HS) [7.5% NaCl] recovers hemodynamic variables and effective circulating volume in hemorrhagic shock [3]. The beneficial effect of HS is associated with its anti-inflammatory effect, evidenced by inhibition of neutrophil activation and infiltration in lungs [4]. Neutrophil activation can release cytokines, reactive oxygen species, and enzymes, resulting in injuries of organs and tissues [5]. Furthermore, HS can ameliorate organ dysfunction in severe sepsis caused by cecal ligation and puncture (CLP), which is mediated via its antioxidant and anti-inflammatory effects [6]. Recently, HS has been revealed to prevent early myocardial dysfunction and to reduce myocardial apoptosis [7].

Macrophage migration inhibitory factor (MIF) is one of the important factors in sepsis. MIF is ubiquitously expressed in both immune and nonimmune cells including various peripheral tissues. MIF can recruit immune cells (macrophages, eosinophils, basophils, neutrophils) to the site of inflammation, leading to amplify the production of various proinflammatory cytokines and mediators such as IL-1 , TNF- , IFN-γ, IL-17, and nitric oxide (NO) [8]. After injection of LPS in rodents, MIF protein was released from several organs, such as lung, liver, kidney, adrenal and pituitary gland, spleen, and skin [9]. MIF protein expression also significantly increased in hearts of septic mice [10, 11]. Recently, it has been demonstrated that HS reduces the levels of MIF in LPS-induced macrophage cell line [12]. MIF neutralization by anti-MIF antibody can reverse endotoxin-induced myocardial dysfunction in rats [13]. Therefore, we examined whether neutrophil infiltration and MIF expression are involved in the cardioprotective effect of HS in a conscious rat model of LPS-induced sepsis.

influx through the L-type channel (LTCCs) of sarcolemma of myocardium during an action potential initiates contraction of the cardiac myocytes. current subsequently triggers a larger release from the sarcoplasmic reticulum (SR) via ryanodine receptors, resulting in elevation of intracellular concentration ( ), and providing for the excitation-contraction coupling [14]. In this study, we further measured the amplitude of transients in isolated single cardiomyocytes to evaluate whether HS can preserve handling capacity to improve cardiac contractile function during sepsis.

2. Materials and Methods

2.1. Experimental Animals

Male Wistar rats (10–12 weeks old, 280–300 g) were used and purchased from the National Laboratory Animal Breeding and Research Center of the National Science Council, Taiwan. Handling of the animals conforms to the Guide for the Care and Use of Laboratory Animals, published by the National Institutes of Health, USA (NIH publication number 85-23, revised in 1996). All animal cares and experimental protocols in this study were approved by the Animal Care and Use Committee of National Defense Medical Center, Taipei, Taiwan. Animals were housed under a 12 h light-dark cycle room with an ambient temperature of °C and humidity of %. The animal preparation for anesthetization and cannulation of blood vessels were performed as described previously [15].

2.2. Experimental Groups

The experiments of sepsis were performed on conscious rats, which has been reported to be a clinically relevant sepsis model [16] and avoids the interference of anesthetics with cytokine release [17]. Animals were divided into four groups: (1) sham (normal saline, 0.9% NaCl, 4 mL/kg, intravenously), ; (2) sham + HS (7.5% NaCl, 4 mL/kg, intravenously), ; (3) LPS: rats were treated with Escherichia coli LPS 10 mg/kg (intravenous infusion for 10 min). One hour after LPS administration, 0.9% NaCl (4 mL/kg, 300 mosmole/L) was given intravenously, ; (4) LPS + HS: rats were treated with Escherichia coli LPS 10 mg/kg (intravenous infusion for 10 min). One hour after LPS administration, 7.5% NaCl (4 mL/kg, 2400 mosmole/L) was given, . Normal saline and HS were infused with a rate of 0.2 mL/min [18, 19]. At 0, 1, 2, 4, and 6 h after LPS infusion, the changes in hemodynamics (blood pressure and heart rate), hepatic function index (i.e., alanine aminotransferase (ALT), aspartate aminotransferase (AST)), cell toxicity index (i.e., lactate dehydrogenase (LDH)), and renal function index (creatinine (CRE)), as well as the plasma levels of sodium, potassium, and calcium ion concentration were examined. Six hours after LPS infusion, animals were sacrificed and hearts were collected immediately.

2.3. Isolated Heart Preparation and Left Ventricular Pressure Recording

The preparation for heart isolation and measurement of cardiac contractility were performed as described previously [15]. Hearts were isolated 6 h after LPS administration and mounted on the Langendorff apparatus (ML785B2 Langendorff System Bundle, AD instruments). The left ventricular developed pressure (LVDP) and the mean rates of contraction ( ) and relaxation ( ) were measured.

2.4. Measurement of Blood Electrolytes

Whole blood levels of sodium, potassium, and calcium ion in rats 6 hours after LPS infusion were measured by an arterial blood gas analyzer (AVL OPTI Critical Care Analyzer; AVL Scientific Corp., Roswell, USA).

2.5. MPO Activity Test

MPO activity has been demonstrated to correlate with the number of neutrophils [20] and was used as an index of neutrophil accumulation in the heart. It was determined using an MPO assay kit (CytoStore, Calgary, Canada) by measuring the H2O2-dependent oxidation of O-dianisidine, according to the manufacturer’s instructions. MPO activity is expressed as unit per mg protein (U/mg protein).

2.6. Western Blot Analysis

The left ventricular myocardium was isolated 6 hours after LPS administration, which was immediately frozen in liquid nitrogen, and stored at −80°C until processed. Detection of phospho-p65 and MIF by Western blotting was performed as described previously [15]. The primary antibodies in this experiment were mouse monoclonal anti-phospho-p65 (Epitomics, USA; 1 : 1000), and rabbit polyclonal anti-MIF (BioVision, USA; 1 : 1000).

2.7. Cardiomyocyte Isolation and Measurement of the Intracellular Calcium

Six hours after LPS administration, the heart was isolated. The methodology of tissue preparations and cardiomycytes isolation were followed and modified from previous studies [21, 22]. Intracellular calcium ( ) was recorded by an indo-1 fluorometric ratio technique. The fluorescent indicator indo-1 was loaded by incubating the myocytes of ventricle in sham, LPS, and LPS + HS groups at room temperature (25°C) for 20 to 30 minutes with 25 μM of indo-1/AM (Sigma Chemical, St. Louis, MO). The transient was measured during a 2 Hz field-stimulation with 10-ms twice-threshold strength square-wave pulses. The fluorescence ratio data were processed and stored in a computer using software (OSP-SFCA; Olympus). Sarcoplasmic reticulum (SR) content was estimated by adding 20 mM caffeine after electric stimulation at 2 Hz for at least 30 s. The total SR content was measured from the amplitude of caffeine-induced transients.

2.8. Statistical Analysis

The data are expressed as means ± SEM. Statistical evaluation was performed with one-factor analysis of variance followed by the Newman-Keuls post hoc comparison test. A value of less than 0.05 was deemed significant.

3. Results

3.1. Effects of HS on Hemodynamic Variables

The mean arterial blood pressure (MBP), heart rate, and rate-pressure product are shown in Figure 1. Rate-pressure product is provided by calculation using systolic blood pressure and heart rate and can reflect the cardiac work in vivo [23]. The basal MBP, heart rate, and rate-pressure product did not show significant differences. In sham and sham + HS groups, there were no significant changes in these variables throughout the experiment. In LPS group, MBP decreased gradually after LPS administration, which lasted until 1 h, and then progressively increased between 1 and 2 h, followed by a continued decrease between 2 and 6 h (Figure 1(a)). The MBP in LPS + HS group also initially decreased after LPS administration and recovered between 4 and 6 h, which is significantly higher than LPS group. After LPS administration, heart rate significantly elevated and peaked at 2 h, and then gradually decreased to basal level at 6 h. In LPS + HS group, the tachycardia caused by LPS lasted to 6 h, which was significantly higher than LPS group (Figure 1(b)). Furthermore, LPS challenge caused a marked reduction in rate-pressure product during 4–6 h. Posttreatment of HS markedly improved the reduced rate-pressure product caused by LPS (Figure 1(c)).

3.2. Effects of HS on Cardiac Contractile Dysfunction Caused by LPS

The LVDP (Figure 2(a)) and average (Figures 2(b) and 2(c)) were measured at 6 h after LPS administration, which was significantly reduced in LPS group compared with sham group ( ). After HS administration, LVDP and significantly improved when compared with LPS group ( ). HS alone (sham + HS group) did not affect the cardiac contractile function compared with sham group.

3.3. Effects of HS on Liver and Renal Dysfunction and Cell Toxicity Caused by LPS

The basal levels of AST, ALT, CRE, and LDH were not significantly different. LPS administration induced elevation of plasma levels of AST, ALT, CRE, and LDH at 6 h. The differences between 6 h levels and basal levels of AST, ALT, and LDH in the LPS group were significantly higher than sham group (Figures 3(a), 3(b), and 3(d)). HS treatment significantly decreased the elevation of AST, ALT, and LDH. The elevated CRE level caused by LPS also significantly attenuated after HS treatment (Figure 3(c)).

3.4. Effects of HS on MPO Activity in Ventricle after LPS Treatment

Treating sham rats with HS revealed a slight reduction in cardiac MPO activity (Figure 4). Six hours after LPS challenge, MPO activity increased by 4 folds compared with sham group ( ). HS treatment significantly suppressed MPO activity of LPS-challenged rats to the level similar to sham group ( ).

3.5. Effects of HS on Protein Expression in Rat Heart after LPS Treatment

The protein expression of MIF (Figure 5) and phospho-p65 (Figure 6) was significantly elevated after 6 h LPS administration ( ). HS treatment significantly suppressed LPS-induced increases in MIF and phospho-p65 protein expression ( ).

3.6. Effects of HS on Ion Concentrations in Blood after LPS Treatment

Treating HS with sham-operated rats did not show elevation of Na+, K+, and concentrations in blood. LPS administration can cause a significant reduction in Na+ concentration at 6 h compared with sham group. A dramatic elevation of Na+ concentration was found in LPS + HS group compared with sham and LPS groups (Figure 7(a)). By contrast, LPS resulted in marked increase of K+ concentration when compared with sham group. Receiving HS treatment, LPS-treated rats showed marked reduction in K+ concentration to levels similar to those of sham group (Figure 7(b)). Moreover, LPS resulted in a significant reduction in concentration in blood at 6 h compared with sham group, which was reversed by HS treatment (Figure 7(c)).

3.7. Effects of HS on Intracellular Concentration in Rat Heart after LPS Treatment

As shown in Figure 8, the electrical-stimulation transient of ventricular cardiomyocytes significantly reduced 6 h after LPS challenge, which was significantly recovered by HS treatment. Similarly, the caffeine-induced transient was significantly reduced 6 h after LPS challenge. However, HS did not significantly affect this change.

4. Discussion

The present study demonstrated that posttreatment with HS can ameliorate circulatory failure including hypotension and cardiac dysfunction caused by LPS-induced sepsis in a conscious rat model. The cardioprotective effect of HS is associated with improvement of handling process, attenuation of neutrophil infiltration, MIF protein expression, and transcription factor NF- B activation in myocardium.

Shih et al. [6] demonstrated similar results in peritonitis-induced septic shock, which are related to the anti-inflammatory and antioxidant effect of HS. We further demonstrated that posttreatment with HS significantly showed cardioprotective effects, which were evidenced by increased contractile function and maintenance of compensatory tachycardia 6 h after LPS challenge. HS provides an intravascular hypertonic environment, leading to increase of the plasma volume, which may contribute to improve the cardiac output, blood flow, and multiple organ function.

It has been shown that MPO in myocardial tissue significantly increased in LPS-induced sepsis [24]. MPO will be released when neutrophils infiltrate into the organs. Ninety percent of MPO released from neutrophils. Measuring the content of MPO can speculate neutrophil infiltration in organs and tissues [25]. MPO expression in left ventricular myocytes was significantly higher in failed hearts, suggesting that overexpression of MPO caused damages to the cardiac function [26]. HS administration significantly reduced MPO accumulation in the myocardial tissue, indicating that neutrophil infiltration was reduced by HS. This anti-inflammatory effect is likely to contribute to the cardioprotection of HS.

Plasma MIF content peaks in early sepsis [27]. Overexpression of MIF protein in sepsis causes cardiac dysfunction [11]. MIF antibody treatment can preserve the cardiac function of mice in sepsis [13]. In this study, HS significantly reduced MIF protein expression in myocardium and maintained cardiac function, suggesting that the inhibitory effect on MIF production contributes to the cardioprotection of HS in sepsis. Inhibition of MIF can suppress NF- B activation, whereas inhibition of NF- B activity significantly attenuates MIF performance [28]. In this study, HS can reduce NF- B activation in cardiac tissue (Figure 6). Therefore, we suggest that, via suppression of neutrophil infiltration into, myocardium, HS attenuates inflammation-related responses, for example, MIF release by immune cells and NF- B activation in cardiomyocytes during sepsis. The inhibitory effect on NF- B activation contributes to decrease in MIF production, by which cardiac contractile function was protected.

Clinical sepsis patients often have low blood sodium phenomena coincide [29]. In the present study, we also found that sodium ion concentration in blood of LPS group is significantly lower than sham group. The underlying mechanism is still uncertain. Hyponatremia may be due to cytokines-induced downregulation of angiotensin II type 1 receptors, resulting in impaired regulation of sodium and water balance by aldosterone and leading to sodium and water loss [30]. After five hours of HS post-treatment, the sodium ion concentration about 153 mmol/L in LPS + HS group, which was significantly higher than another groups. In a previous study, hypernatremic phenomenon has been shown to suppress human phagocytic activity and superoxide anion production [31]. HS supplement can increase the sodium concentration and may reduce neutrophil activation in LPS-induced sepsis.

Furthermore, HS reverses hypocalcemia induced by LPS (Figure 7(c)). A similar result has been demonstrated in a cecal ligation and puncture-induced peritonitis of rats [32]. Sepsis can induce hypocalcemia, which is associated with intracellular accumulation [33]. Elevated intracellular levels have been reported to activate -dependent proteolytic enzymes, leading to tissue damage in sepsis [34]. In a previous study, HS dextran demonstrated to attenuate diastolic levels of in cardiomyocyte after burn complicated with sepsis in late stage [35]. In this study, the electrically-induced transient was measured to observe the influx of via the L-type channel upon electrical stimulation, which then triggers release of from the sarcoplasmic reticulum, leading to muscle contraction. The electrically induced transient is directly related to contractility [36]. HS supplement in early sepsis can improve the amplitude of intracellular transient, which was significantly reduced in our acute sepsis model, indicating the intracellular handling process was recovered (Figure 8). We also found the caffeine-induced transient significantly reduced during sepsis, indicating the content of SR decreased, leading to a reduction in release from SR and the decrease in contractility. The content of SR was elevated after HS treatment. Therefore, HS may improve cardiac contractile function via maintenance of intracellular homeostasis. On the other hand, proinflammatory cytokines, such as TNF- and IL-1 , have been implicated in ventricular dysfunction associated with sepsis [37, 38]. TNF- and IL-1 increase the SR leak from the SR, which contributes to the depressed transient and contractility [39]. Therefore, the anti-inflammatory effect of HS can contribute to maintain handling capacity to improve the cardiac contractile function.

5. Conclusion

HS improved cardiac contractile function and homeostasis in sepsis, which contribute to ameliorate circulatory failure and to maintain multiple organ function. Attenuation of neutrophil infiltration, suppression of NF- B activation, and reduced MIF production in myocardium are associated with the cardioprotective effect of HS in sepsis.


This work was supported by research Grants from the Ministry of National Defense (DOD96-01-05) and the Chi-Mei Hospital (CMNDMC9913), Taiwan.


  1. S. L. Zanotti-Cavazzonia and S. M. Hollenberg, “Cardiac dysfunction in severe sepsis and septic shock,” Current Opinion in Critical Care, vol. 15, no. 5, pp. 392–397, 2009. View at: Publisher Site | Google Scholar
  2. R. P. Dellinger, M. M. Levy, J. M. Carlet et al., “Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008,” Intensive Care Medicine, vol. 34, pp. 17–60, 2008. View at: Google Scholar
  3. L. M. Schmall, W. W. Muir, and J. T. Robertson, “Haemodynamic effects of small volume hypertonic saline in experimentally induced haemorrhagic shock,” Equine Veterinary Journal, vol. 22, no. 4, pp. 273–277, 1990. View at: Google Scholar
  4. J. L. Pascual, K. A. Khwaja, L. E. Ferri et al., “Hypertonic saline resuscitation attenuates neutrophil lung sequestration and transmigration by diminishing leukocyte-endothelial interactions in a two-hit model of hemorrhagic shock and infection,” Journal of Trauma, vol. 54, no. 1, pp. 121–132, 2003. View at: Publisher Site | Google Scholar
  5. Y.-M. Yao, H. Redl, S. Bahrami, and G. Schlag, “The inflammatory basis of trauma/shock-associated multiple organ failure,” Inflammation Research, vol. 47, no. 5, pp. 201–210, 1998. View at: Publisher Site | Google Scholar
  6. C.-C. Shih, S.-J. Chen, A. Chen, J.-Y. Wu, W.-J. Liaw, and C.-C. Wu, “Therapeutic effects of hypertonic saline on peritonitis-induced septic shock with multiple organ dysfunction syndrome in rats,” Critical Care Medicine, vol. 36, no. 6, pp. 1864–1872, 2008. View at: Publisher Site | Google Scholar
  7. B. Hogue, F. Chagnon, and O. Lesur, “Resuscitation fluids and endotoxin-induced myocardial dysfunction: is selection a load-independent differential issue?” Shock, vol. 38, pp. 307–313, 2012. View at: Google Scholar
  8. I. Stojanovic, T. Saksida, and S. Stosic-Grujicic, “Beta cell function: the role of macrophage migration inhibitory factor,” Immunologic Research, vol. 52, no. 1-2, pp. 81–88, 2012. View at: Publisher Site | Google Scholar
  9. H. Lue, R. Kleemann, T. Calandra, T. Roger, and J. Bernhagen, “Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease,” Microbes and Infection, vol. 4, no. 4, pp. 449–460, 2002. View at: Publisher Site | Google Scholar
  10. L. B. Garner, M. S. Willis, D. L. Carlson et al., “Macrophage migration inhibitory factor is a cardiac-derived myocardial depressant factor,” The American Journal of Physiology, vol. 285, no. 6, pp. H2500–H2509, 2003. View at: Google Scholar
  11. T. Ha, F. Hua, D. Grant et al., “Glucan phosphate attenuates cardiac dysfunction and inhibits cardiac MIF expression and apoptosis in septic mice,” The American Journal of Physiology, vol. 291, no. 4, pp. H1910–H1918, 2006. View at: Publisher Site | Google Scholar
  12. J. Y. Kim, S. H. Choi, Y. H. Yoon et al., “Effects of hypertonic saline on macrophage migration inhibitory factor in traumatic conditions,” Experimental and Therapeutic Medicine, vol. 5, pp. 362–366, 2013. View at: Google Scholar
  13. F. Chagnon, C. N. Metz, R. Bucala, and O. Lesur, “Endotoxin-induced myocardial dysfunction: effects of macrophage migration inhibitory factor neutralization,” Circulation Research, vol. 96, no. 10, pp. 1095–1102, 2005. View at: Publisher Site | Google Scholar
  14. K. M. Dibb, H. K. Graham, L. A. Venetucci, D. A. Eisner, and A. W. Trafford, “Analysis of cellular calcium fluxes in cardiac muscle to understand calcium homeostasis in the heart,” Cell Calcium, vol. 42, no. 4-5, pp. 503–512, 2007. View at: Publisher Site | Google Scholar
  15. Y.-M. Lee, P.-Y. Cheng, L.-S. Chim et al., “Baicalein, an active component of Scutellaria baicalensis Georgi, improves cardiac contractile function in endotoxaemic rats via induction of heme oxygenase-1 and suppression of inflammatory responses,” Journal of Ethnopharmacology, vol. 135, no. 1, pp. 179–185, 2011. View at: Publisher Site | Google Scholar
  16. G. Mathiak, D. Szewczyk, F. Abdullah, P. Ovadia, G. Feuerstein, and R. Rabinovici, “An improved clinically relevant sepsis model in the conscious rat,” Critical Care Medicine, vol. 28, no. 6, pp. 1947–1952, 2000. View at: Google Scholar
  17. F. L. Yang, C. H. Li, B. G. Hsu et al., “The reduction of tumor necrosis factor-α release and tissue damage by pentobarbital in the experimental endotoxemia model,” Shock, vol. 28, no. 3, pp. 309–316, 2007. View at: Publisher Site | Google Scholar
  18. J. de Felippe Jr., J. Timoner, and I. T. Velasco, “Treatment of refractory hypovolaemic shock by 7.5% sodium chloride injections,” The Lancet, vol. 2, no. 8202, pp. 1002–1004, 1980. View at: Google Scholar
  19. A. L. Johnson and L. M. Criddle, “Pass the salt: indications for and implications of using hypertonic saline,” Critical Care Nurse, vol. 24, no. 5, pp. 36–46, 2004. View at: Google Scholar
  20. K. M. Mullane, R. Kraemer, and B. Smith, “Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium,” Journal of Pharmacological Methods, vol. 14, no. 3, pp. 157–167, 1985. View at: Publisher Site | Google Scholar
  21. W. Wongcharoen, Y.-C. Chen, Y.-J. Chen et al., “Effects of a Na+/Ca2+ exchanger inhibitor on pulmonary vein electrical activity and ouabain-induced arrhythmogenicity,” Cardiovascular Research, vol. 70, no. 3, pp. 497–508, 2006. View at: Publisher Site | Google Scholar
  22. Y.-C. Chen, Y.-H. Kao, C.-F. Huang, C.-C. Cheng, Y.-J. Chen, and S.-A. Chen, “Heat stress responses modulate calcium regulations and electrophysiological characteristics in atrial myocytes,” Journal of Molecular and Cellular Cardiology, vol. 48, no. 4, pp. 781–788, 2010. View at: Publisher Site | Google Scholar
  23. M.-T. Chung, P.-Y. Cheng, K.-K. Lam et al., “Cardioprotective effects of long-term treatment with raloxifene, a selective estrogen receptor modulator, on myocardial ischemia/reperfusion injury in ovariectomized rats,” Menopause, vol. 17, no. 1, pp. 127–134, 2010. View at: Publisher Site | Google Scholar
  24. H. Fauvel, P. Marchetti, G. Obert et al., “Protective effects of cyclosporin A from endotoxin-induced myocardial dysfunction and apoptosis in rats,” The American Journal of Respiratory and Critical Care Medicine, vol. 165, no. 4, pp. 449–455, 2002. View at: Google Scholar
  25. K. Brown, S. Brain, J. Pearson, J. Edgeworth, S. Lewis, and D. Treacher, “Neutrophils in development of multiple organ failure in sepsis,” The Lancet, vol. 368, no. 9530, pp. 157–169, 2006. View at: Publisher Site | Google Scholar
  26. V. Rudolph, T. K. Rudolph, J. C. Hennings et al., “Activation of polymorphonuclear neutrophils in patients with impaired left ventricular function,” Free Radical Biology and Medicine, vol. 43, no. 8, pp. 1189–1196, 2007. View at: Publisher Site | Google Scholar
  27. N. C. Riedemann, R.-F. Guo, and P. A. Ward, “Novel strategies for the treatment of sepsis,” Nature Medicine, vol. 9, no. 5, pp. 517–524, 2003. View at: Publisher Site | Google Scholar
  28. W.-G. Cao, M. Morin, C. Metz, R. Maheux, and A. Akoum, “Stimulation of macrophage migration inhibitory factor expression in endometrial stromal cells by interleukin 1, beta involving the nuclear transcription factor NFκB,” Biology of Reproduction, vol. 73, no. 3, pp. 565–570, 2005. View at: Publisher Site | Google Scholar
  29. T. Sharshar, A. Blanchard, M. Paillard, J. C. Raphael, P. Gajdos, and D. Annane, “Circulating vasopressin levels in septic shock,” Critical Care Medicine, vol. 31, no. 6, pp. 1752–1758, 2003. View at: Publisher Site | Google Scholar
  30. T. K. Desai, R. W. Carlson, and M. A. Geheb, “Prevalence and clinical implications of hypocalcemia in acutely ill patients in a medical intensive care setting,” The American Journal of Medicine, vol. 84, no. 2, pp. 209–214, 1988. View at: Google Scholar
  31. T. Kuroda, T. Harada, H. Tsutsumi, and M. Kobayashi, “Hypernatremic suppression of neutrophils,” Burns, vol. 23, no. 4, pp. 338–340, 1997. View at: Publisher Site | Google Scholar
  32. C. C. Shih, M. F. Tsai, S. J. Chen et al., “Effects of small-volume hypertonic saline on acid-base and electrolytes balance in rats with peritonitis-induced sepsis,” Shock, vol. 38, pp. 649–655, 2012. View at: Google Scholar
  33. S.-K. Song, I. E. Karl, J. J. H. Ackerman, and R. S. Hotchkiss, “Increased intracellular Ca2+: a critical link in the pathophysiology of sepsis?” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 9, pp. 3933–3937, 1993. View at: Google Scholar
  34. L. Voisin, D. Breuillé, L. Combaret et al., “Muscle wasting in a rat model of long-lasting sepsis results from the activation of lysosomal, Ca+2-activated, and ubiquitin-proteasome proteolytic pathways,” Journal of Clinical Investigation, vol. 97, no. 7, pp. 1610–1617, 1996. View at: Google Scholar
  35. J. W. Horton, D. L. Maass, and D. J. White, “Hypertonic saline dextran after burn injury decreases inflammatory cytokine responses to subsequent pneumonia-related sepsis,” The American Journal of Physiology, vol. 290, no. 4, pp. H1642–H1650, 2006. View at: Publisher Site | Google Scholar
  36. J.-M. Pei, X.-C. Yu, M.-L. Fung et al., “Impaired G(s)α and adenylyl cyclase cause β-adrenoceptor desensitization in chronically hypoxic rat hearts,” The American Journal of Physiology, vol. 279, no. 5, pp. C1455–C1463, 2000. View at: Google Scholar
  37. A. Kumar, V. Thota, L. Dee, J. Olson, E. Uretz, and J. E. Parrillo, “Tumor necrosis factor α and interleukin 1β are responsible for in vitro myocardial cell depression induced by human septic shock serum,” Journal of Experimental Medicine, vol. 183, no. 3, pp. 949–958, 1996. View at: Publisher Site | Google Scholar
  38. C. Stamm, D. B. Cowan, I. Friehs, S. Noria, P. J. Del Nido, and F. X. McGowan Jr., “Rapid endotoxin-induced alterations in myocardial calcium handling: obligatory role of cardiac TNF-α,” Anesthesiology, vol. 95, no. 6, pp. 1396–1405, 2001. View at: Google Scholar
  39. D. J. Duncan, Z. Yang, P. M. Hopkins, D. S. Steele, and S. M. Harrison, “TNF-α and IL-1β increase Ca2+ leak from the sarcoplasmic reticulum and susceptibility to arrhythmia in rat ventricular myocytes,” Cell Calcium, vol. 47, no. 4, pp. 378–386, 2010. View at: Publisher Site | Google Scholar

Copyright © 2013 Yi-Li Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

1186 Views | 630 Downloads | 4 Citations
 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.